Weild’s keynote explored the intersection of the democratization of capital and healthcare innovation, which has sparked a new way for medtech startups to raise money outside of traditional venture capital or private equity paths. David also highlights how the JOBS Act is changing the healthtech and pharmaceutical industry. "It's gratifying to see so many Medtech companies using the JOBS Act since we created it in large part to fund innovative growth companies and social impact."
Join us at the next LSI Emerging Medtech Summit
LSI's global events attract top innovators, active investors, and deal-making strategics.GET INFO